Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
150.00
-1.27 (-0.84%)
Dec 5, 2025, 4:00 PM EST - Market closed
Belite Bio Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Belite Bio stock have an average target of 149, with a low estimate of 80 and a high estimate of 194. The average target predicts a decrease of -0.67% from the current stock price of 150.00.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Belite Bio stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 4 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 2 | 3 |
| Hold | 0 | 0 | 0 | 0 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 5 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho | Mizuho | Hold → Buy Upgrades $105 → $194 | Hold → Buy | Upgrades | $105 → $194 | +29.33% | Dec 2, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $98 → $185 | Strong Buy | Maintains | $98 → $185 | +23.33% | Dec 1, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $154 | Buy | Initiates | $154 | +2.67% | Nov 24, 2025 |
| Mizuho | Mizuho | Hold Initiates $105 | Hold | Initiates | $105 | -30.00% | Nov 20, 2025 |
| Benchmark | Benchmark | Strong Buy Maintains $80 → $132 | Strong Buy | Maintains | $80 → $132 | -12.00% | Oct 31, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
17.00M
EPS This Year
-2.15
from -1.18
EPS Next Year
-1.76
from -2.15
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | n/a | 52.5M | ||||
| Avg | n/a | 17.0M | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -2.07 | -0.63 | ||||
| Avg | -2.15 | -1.76 | ||||
| Low | -2.22 | -2.50 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.